TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 122 filers reported holding TANGO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $608 | -58.3% | 70,811 | -61.4% | 0.00% | -100.0% |
Q1 2024 | $1,458 | -27.1% | 183,486 | -9.1% | 0.00% | 0.0% |
Q4 2023 | $1,999 | +101.9% | 201,899 | +129.7% | 0.00% | 0.0% |
Q3 2023 | $990 | +429.4% | 87,882 | +56.2% | 0.00% | – |
Q2 2023 | $187 | -20.4% | 56,264 | -5.5% | 0.00% | – |
Q1 2023 | $235 | -60.8% | 59,529 | -27.9% | 0.00% | – |
Q4 2022 | $599 | -99.9% | 82,522 | -31.1% | 0.00% | – |
Q3 2022 | $433,000 | -31.2% | 119,715 | -13.8% | 0.00% | – |
Q2 2022 | $629,000 | -32.5% | 138,836 | +13.0% | 0.00% | -100.0% |
Q1 2022 | $932,000 | – | 122,909 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 19,201,475 | $164,748,656 | 81.48% |
Mass General Brigham, Inc | 354,192 | $3,038,967 | 14.80% |
Nextech Invest Ltd. | 5,533,980 | $47,481,548 | 7.99% |
Boxer Capital, LLC | 8,198,642 | $70,344,348 | 3.70% |
EcoR1 Capital, LLC | 13,330,736 | $114,377,715 | 3.50% |
Braslyn Ltd. | 26,961 | $231,325 | 2.77% |
Bain Capital Life Sciences Investors, LLC | 2,892,663 | $24,819,049 | 2.72% |
SUPERSTRING CAPITAL MANAGEMENT LP | 115,571 | $991,599 | 1.25% |
Samsara BioCapital, LLC | 630,000 | $5,405,400 | 1.13% |
Southpoint Capital Advisors LP | 5,276,699 | $45,274,077 | 1.13% |